Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to Glioblastoma
- Univ. of California, Berkeley, CA (United States). Dept. of Chemistry
- Univ. of California, San Francisco, CA (United States). Dept. of Neurological Surgery
- NYU Langone Medical Center, New York, NY (United States). Dept. of Pediatrics
- Univ. of California, Berkeley, CA (United States). Dept. of Chemistry; Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Materials Sciences Division
Glioblastoma is a particularly challenging cancer, as there are currently limited options for treatment. New delivery routes are being explored, including direct intratumoral injection via convection-enhanced delivery (CED). While promising, convection-enhanced delivery of traditional chemotherapeutics such as doxorubicin (DOX) has seen limited success. Several studies have demonstrated that attaching a drug to polymeric nanoscale materials can improve drug delivery efficacy via CED. We therefore set out to evaluate a panel of morphologically distinct protein nanoparticles for their potential as CED drug delivery vehicles for glioblastoma treatment. The panel consisted of three different virus-like particles (VLPs), MS2 spheres, tobacco mosaic virus (TMV) disks and nanophage filamentous rods modified with DOX. While all three VLPs displayed adequate drug delivery and cell uptake in vitro, increased survival rates were only observed for glioma-bearing mice that were treated via CED with TMV disks and MS2 spheres conjugated to doxorubicin, with TMV-treated mice showing the best response. Importantly, these improved survival rates were observed after only a single VLP–DOX CED injection several orders of magnitude smaller than traditional IV doses. Overall, this study underscores the potential of nanoscale chemotherapeutic CED using virus-like particles and illustrates the need for further studies into how the overall morphology of VLPs influences their drug delivery properties.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1571946
- Journal Information:
- Nanomaterials, Journal Name: Nanomaterials Journal Issue: 12 Vol. 8; ISSN 2079-4991; ISSN NANOKO
- Publisher:
- MDPICopyright Statement
- Country of Publication:
- United States
- Language:
- English
Probing Reversible Guest Binding with Hyperpolarized 129Xe-NMR: Characteristics and Applications for Cucurbit[n]urils
|
journal | February 2020 |
Rotaxane Probes for the Detection of Hydrogen Peroxide by 129 Xe HyperCEST NMR Spectroscopy
|
journal | June 2019 |
Rotaxane Probes for the Detection of Hydrogen Peroxide by 129 Xe HyperCEST NMR Spectroscopy
|
journal | July 2019 |
Similar Records
Nanometer-Scale, Particle-Based Immunotherapy for Cancer Treatment (LDRD Final Report: 17-LW-051)
Synthesis and characterization of polylactide/doxorubicin/magnetic nanoparticles composites for drug delivery
Temperature-Responsive Polymersomes of Poly(3-methyl-N-vinylcaprolactam)-block-poly(N-vinylpyrrolidone) To Decrease Doxorubicin-Induced Cardiotoxicity
Technical Report
·
Thu Oct 25 00:00:00 EDT 2018
·
OSTI ID:1959432
Synthesis and characterization of polylactide/doxorubicin/magnetic nanoparticles composites for drug delivery
Journal Article
·
Fri May 22 00:00:00 EDT 2015
· AIP Conference Proceedings
·
OSTI ID:22391859
Temperature-Responsive Polymersomes of Poly(3-methyl-N-vinylcaprolactam)-block-poly(N-vinylpyrrolidone) To Decrease Doxorubicin-Induced Cardiotoxicity
Journal Article
·
Mon Sep 09 20:00:00 EDT 2019
· Biomacromolecules
·
OSTI ID:1571842